Syncom Formulations (India) Share Price
Know More₹15.35-0.70 (-4.36%)
28-Feb-2025₹15.34-0.69 (-4.30%)
28-Feb-2025BSE : 524470
NSE : SYNCOMF
Sector : Health care
ISIN Code : INE312C01025
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 28-Feb-2025
| Market Cap (₹ Cr) | 1,443 |
Traded Value (₹ Cr) | 1.13 |
Volume (Shares) | 7,33,659 |
Face Value (₹) | 1 |
52-Week High (₹) | 27.94 |
52-Week High Date | 10-Sep-2024 |
52-Week Low (₹) | 11.00 |
52-Week Low Date | 05-Jun-2024 |
All Time High (₹) | 27.94 |
All Time High Date | 10-Sep-2024 |
All Time Low (₹) | 0.14 |
All Time Low Date | 15-Jan-1998 |
Syncom Formulations (India) Ltd
Market News
Syncom Formul. Announcement
Syncom Formulations (India) Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 1,442 |
| EPS - TTM (₹) [C] | 0.42 |
| P/E Ratio (X) [C] | 36.52 |
| Face Value (₹) | 1 |
| Latest Dividend (%) | 3.00 |
| Latest Dividend Date | 09-Sep-2022 |
| Dividend Yield (%) | - |
| Book Value Share (₹) [C] | 3.34 |
| P/B Ratio (₹) [C] | 4.59 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | 0.02 | 10,489 | 0.07 |
| Bandhan BSE Healthcare Index Fund - Regular (G) | 0.01 | 6,491 | 0.07 |
| Bandhan BSE Healthcare Index Fund - Direct (G) | 0.01 | 6,491 | 0.07 |
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 15.23 16.00 |
| Week Low/High (₹) | 15.23 18.00 |
| Month Low/High (₹) | 15.23 19.00 |
| Year Low/High (₹) | 10.95 28.00 |
| All time Low/High (₹) | 0.14 28.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -9.76% | -9.76% | -2.81% | -2.94% |
| 1 Month | -8.64% | -8.74% | -3.56% | -3.63% |
| 3 Month | -24.36% | -24.32% | -7.40% | -7.48% |
| 6 Month | -25.17% | -25.17% | -10.50% | -11.69% |
| 1 Year | 8.26% | 8.41% | 1.24% | 0.79% |
| 3 Year | 61.47% | - | 30.14% | 31.74% |
Company Info
Company Information
Chairman & Wholetime Director : Kedarmal Bankda
Managing Director : Vijay Shankarlal Bankda
Whole-time Director : Rinki Bankda
Independent Director : Ruchi Jindal
Company Sec. & Compli. Officer : Vaishali Agrawal
Independent Director : Ritesh Kumar Lunkad
Independent Director : Ankit Jain
Registered Office: 7 Niraj Indl Estate Andheri(E), Off Mahakali Caves Rd,Mumbai,Maharashtra-400093 Ph: 91-22-30887744
FAQs about Syncom Formulations (India) Ltd
1. What's the Syncom Formulations (India) Ltd share price today?
Syncom Formulations (India) Ltd share price was Rs 15.35 at close on 28th Feb 2025. Syncom Formulations (India) Ltd share price was down by 4.36% from the previous closing price of Rs 16.05. Syncom Formulations (India) Ltd share price trend:
- Last 1 Month: Syncom Formulations (India) Ltd share price moved down by 8.64% on BSE
- Last 3 Months: Syncom Formulations (India) Ltd share price moved down by 24.36% on BSE
- Last 12 Months: Syncom Formulations (India) Ltd share price moved up by 8.26% on BSE
- Last 3 Years: Syncom Formulations (India) Ltd price moved up by 61.47% on BSE
2. How can I quickly analyse the performance of the Syncom Formulations (India) Ltd stock?
The performance of the Syncom Formulations (India) Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 36.52
- Price to book value ratio is 4.59
- Dividend yield of 0.00
- The EPS (trailing 12 months) of the Syncom Formulations (India) Ltd stock is Rs 0.42
3. What is the market cap of Syncom Formulations (India) Ltd?
Syncom Formulations (India) Ltd has a market capitalisation of Rs 1,443 crore.
4. What is Syncom Formulations (India) Ltd's 52-week high/low share price?
The Syncom Formulations (India) Ltd’s 52-week high share price is Rs 27.94 and 52-week low share price is Rs 11.00.
5. Is the Syncom Formulations (India) Ltd profitable?
On a consolidated basis, Syncom Formulations (India) Ltd reported a profit of Rs 12.79 crore on a total income of Rs 130.85 crore for the quarter ended 2024. For the year ended Dec 2024, Syncom Formulations (India) Ltd had posted a profit of Rs 13.00 crore on a total income of Rs 131.57 crore.
6. Which are Syncom Formulations (India) Ltd’s peers in the Health care sector?
Syncom Formulations (India) Ltd’s top 5 peers in the Health care sector are SMS Pharma., Windlas Biotech, Themis Medicare, Syncom Formul., Jagsonpal Pharma, Bliss GVS Pharma, Hester Bios.
7. Who owns how much in Syncom Formulations (India) Ltd?
Key changes to the Syncom Formulations (India) Ltd shareholding are as follows:
- Promoter holding in Syncom Formulations (India) Ltd has gone up to 50.57 per cent as of Dec 2024 from 50.57 per cent as of Mar 2024.
